TITLE

Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?

AUTHOR(S)
ECKEL, ROBERT H.; KAHN, STEVEN E.; FERRANNINI, ELE; GOLDFINE, ALLISON B.; NATHAN, DAVID M.; SCHWARTZ, MICHAEL W.; SMITH, ROBERT J.; SMITH, STEVEN R.
PUB. DATE
June 2011
SOURCE
Diabetes Care;Jun2011, Vol. 34 Issue 6, p1424
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE--This report examines what is known about the relationship between obesity and type 2 diabetes and how future research in these areas might be directed to benefit prevention, interventions, and overall patient care. RESEARCH DESIGN AND METHODS--An international working group of 32 experts in the pathophysiology, genetics, clinical trials, and clinical care of obesity and/or type 2 diabetes participated in a conference held on 6-7 January 2011 and cosponsored by The Endocrine Society, the American Diabetes Association, and the European Association for the Study of Diabetes. A writing group comprising eight participants subsequently prepared this summary and recommendations. Participants reviewed and discussed published literature and their own unpublished data. RESULTS--The writing group unanimously supported the summary and recommendations as representing the working group's majority or unanimous opinions. CONCLUSIONS--The major questions linking obesity to type 2 diabetes that need to be addressed by combined basic, clinical, and population-based scientific approaches include the following: 1) Why do not all patients with obesity develop type 2 diabetes? 2) Through what mechanisms do obesity and insulin resistance contribute to β-cell decompensation, and if/when obesity prevention ensues, how much reduction in type 2 diabetes incidence will follow? 3) How does the duration of type 2 diabetes relate to the benefits of weight reduction by lifestyle, weight-loss drugs, and/or bariatric surgery on β-cell function and glycemia? 4) What is necessary for regulatory approval of medications and possibly surgical approaches for preventing type 2 diabetes in patients with obesity? Improved understanding of how obesity relates to type 2 diabetes may help advance effective and cost-effective interventions for both conditions, including more tailored therapy. To expedite this process, we recommend further investigation into the pathogenesis of these coexistent conditions and innovative approaches to their pharmacological and surgical management.
ACCESSION #
65099020

 

Related Articles

  • Impact of an exercise program on acylcarnitines in obesity: a prospective controlled study. Rodr�guez-Guti�rrez, Ren�; Lavalle-Gonz�lez, Fernando J.; Mart�nez-Garza, Laura E.; Landeros-Olvera, Erick; L�pez-Alvarenga, Juan C.; Torres-Sep�lveda, Maria R.; Gonz�lez-Gonz�lez, Jose G.; Mancillas-Adame, Leonardo G.; Salazar-Gonzalez, Bertha; Villarreal-P�rez, Jesus Z. // Journal of the International Society of Sports Nutrition;2012, Vol. 9 Issue 1, p22 

    Background: Acylcarnitine (AC) transport dysfunction into the mitochondrial matrix is one of the pathophysiological mechanisms of type 2 diabetes mellitus (DM). The effect of an aerobic exercise (AE) program on this condition in obese subjects without DM is unclear. Methods: A prospective,...

  • The Role of Phentermine/Topiramate Extended-release in the Treatment of Obesity and Obesity-related Adverse Health Consequences. Gavin, James R. // U.S. Endocrinology;Winter2013, Vol. 9 Issue 2, p139 

    Long-term pharmacologic strategies that may be used in conjunction with lifestyle changes to combat the obesity epidemic have, until recently, been an unmet clinical need. In 2012, the US Food and Drug Administration (FDA) approved two new drugs for chronic weight management in obese adults in...

  • Spontaneous Type 2 Diabetic Rodent Models. Yang-wei Wang; Guang-dong Sun; Jing Sun; Shu-jun Liu; Ji Wang; Xiao-hong Xu; Li-ning Miao // Journal of Diabetes Research;2013, p1 

    Diabetes mellitus, especially type 2 diabetes (T2DM), is one of the most common chronic diseases and continues to increase in numbers with large proportion of health care budget being used. Many animal models have been established in order to investigate the mechanisms and pathophysiologic...

  • A Look Back … and Forward. Marks, Jennifer B. // Clinical Diabetes;Spring2006, Vol. 24 Issue 2, p51 

    The article presents the author's views on diabetes and diabetes care. A rise in obesity rates is to blame for much of the increase in type 2 diabetes. There are health associations that jointly published a position statement emphasizing the importance of lifestyle modification in weight...

  • Challenges in the Management of Type 2 Diabetes Mellitus and Cardiovascular Risk Factors in Obese Subjects: What Is the Evidence and What Are the Myths? Chhabra, Lovely; Liti, Besiana; Kuraganti, Gayatri; Kaul, Sudesh; Trivedi, Nitin // International Journal of Endocrinology;2013, p1 

    The increasing worldwide prevalence of diabetes mellitus and obesity has projected concerns for increasing burden of cardiovascular morbidity and mortality. The dangers of obesity in adults and children have received more attention than ever in the recent years as more research data becomes...

  • TYPE 2 DIABETES: AN EPIDEMIC IN CHILDREN. Wilson, Valerie // Nursing Children & Young People;Mar2013, Vol. 25 Issue 2, p14 

    Increasing numbers of children and adolescents are developing type 2 diabetes. Symptoms of this condition include obesity, a sedentary lifestyle, insulin resistance and hypertension. Type 2 diabetes is more common in girls and families with a positive history of the disease. Diagnosis is often...

  • Genetic Variation in the Fatty Acid Synthase Gene (FAS) and Its Relation to Type 2 Diabetes and Fat Depot Specific mRNA Expression in Humans. Tönjes, Anke; Berndt, Janin; Böttcher, Yvonne; Enigk, Beate; Reichenbächer, Marlene; Schön, Michael R.; Blüher, Matthias; Wiesner, Tobias; Stumvoll, Michael; Kovacs, Peter // Diabetes;Jun2007 Supplement 1, Vol. 56, pA299 

    Inhibition of fatty acid synthase (FAS) induces a rapid decline in fat stores in mice, suggesting a role for this enzyme in energy homeostasis. Recent findings indicate that the Val14831le substitution in FAS is protective against obesity in Pima Indians. To investigate the potential role of FAS...

  • Gene-Lifestyle Interaction and Type 2 Diabetes: The EPIC InterAct Case-Cohort Study. Langenberg, Claudia; Sharp, Stephen J.; Franks, Paul W.; Scott, Robert A.; Deloukas, Panos; Forouhi, Nita G.; Froguel, Philippe; Groop, Leif C.; Hansen, Torben; Palla, Luigi; Pedersen, Oluf; Schulze, Matthias B.; Tormo, Maria-Jose; Wheeler, Eleanor; Agnoli, Claudia; Arriola, Larraitz; Barricarte, Aurelio; Boeing, Heiner; Clarke, Geraldine M.; Clavel-Chapelon, Françoise // PLoS Medicine;May2014, Vol. 11 Issue 5, p1 

    : In this study, Wareham and colleagues quantified the combined effects of genetic and lifestyle factors on risk of T2D in order to inform strategies for prevention. The authors found that the relative effect of a type 2 diabetes genetic risk score is greater in younger and leaner participants,...

  • Genetics of Type 2 Diabetes- A Review Article. Shahvazian, Ensieh; Yazd, Ehsan Farashahi; Sheikhha, Mohammad Hasan; Rahmanian, Masoud // Iranian Journal of Diabetes & Obesity (IJDO);Winter2015, Vol. 7 Issue 4, p187 

    Objective: Type 2 diabetes (T2D) as a complex disease is the result of genetically heterogeneous factors and environmental issues interaction. Linkage and small-scale candidate gene studies were successful in identification of genetic susceptibilities of monogenic form of diseases. However, they...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics